tert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate

C29H35BrN6O4 — CID 142702551

IUPACtert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate
SMILESCCCCOC(=O)n1nc(-c2nc3c(N4CCN(C)CC4)cccc3n2C(=O)OC(C)(C)C)c2ccc(Br)cc21
InChIInChI=1S/C29H35BrN6O4/c1-6-7-17-39-28(38)36-23-18-19(30)11-12-20(23)24(32-36)26-31-25-21(34-15-13-33(5)14-16-34)9-8-10-22(25)35(26)27(37)40-29(2,3)4/h8-12,18H,6-7,13-17H2,1-5H3
InChIKeyPGZNAIPFEIMHOD-UHFFFAOYSA-N
MW611.54 g/mol
LogP6.14
Rot. Bonds5

About tert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate

tert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate (PubChem CID 142702551) has the molecular formula C29H35BrN6O4 and a molecular weight of 611.54 g/mol. Its IUPAC name is tert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate.

Molecular Properties

Compound Nametert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate
PubChem CID142702551
Molecular FormulaC29H35BrN6O4
Molecular Weight611.54 g/mol
Exact Mass610.19
IUPAC Nametert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate
SMILESCCCCOC(=O)n1nc(-c2nc3c(N4CCN(C)CC4)cccc3n2C(=O)OC(C)(C)C)c2ccc(Br)cc21
InChIInChI=1S/C29H35BrN6O4/c1-6-7-17-39-28(38)36-23-18-19(30)11-12-20(23)24(32-36)26-31-25-21(34-15-13-33(5)14-16-34)9-8-10-22(25)35(26)27(37)40-29(2,3)4/h8-12,18H,6-7,13-17H2,1-5H3
InChIKeyPGZNAIPFEIMHOD-UHFFFAOYSA-N
XLogP6.14
TPSA94.72 Ų
H-Bond Donors
H-Bond Acceptors10
Rotatable Bonds5
Heavy Atoms40
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500611.54
LogP ≤ 56.14
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze tert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate?
The IUPAC name of tert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate (CID 142702551) is tert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate.
What is the SMILES notation for tert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate?
The canonical SMILES for tert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate is CCCCOC(=O)n1nc(-c2nc3c(N4CCN(C)CC4)cccc3n2C(=O)OC(C)(C)C)c2ccc(Br)cc21.
What is the InChIKey of tert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate?
The InChIKey is PGZNAIPFEIMHOD-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H35BrN6O4/c1-6-7-17-39-28(38)36-23-18-19(30)11-12-20(23)24(32-36)26-31-25-21(34-15-13-33(5)14-16-34)9-8-10-22(25)35(26)27(37)40-29(2,3)4/h8-12,18H,6-7,13-17H2,1-5H3.
What are the key properties of tert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate?
tert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate has a molecular weight of 611.54 g/mol, XLogP of 6.14, 5 rotatable bonds, 0 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl 2-(6-bromo-1-butoxycarbonylindazol-3-yl)-4-(4-methylpiperazin-1-yl)benzimidazole-1-carboxylate is sourced from PubChem (CID 142702551), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).